Christopher D Packey1, Matthew A Ciorba. 1. Division of Gastroenterology, Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, USA.
Abstract
PURPOSE OF REVIEW: Injury to the small bowel from ionizing radiation occurs commonly in patients undergoing cancer therapy and less commonly in instances of accidental radiation overexposure. Several lines of evidence now suggest that dynamic interactions between the host's enteric microbiota and innate immune system are important in modulating the intestinal response to radiation. Here, we will review recent developments in the area of acute radiation enteropathy and examine the current state of knowledge regarding the impact of host-microbial interactions in the process. RECENT FINDINGS: There is promise in the development and testing of new clinical biomarkers including serum citrulline. Toll-like receptor agonists and innate immune system signaling pathways including nuclear factor-kappa B profoundly alter intestinal epithelial cell apoptosis and crypt survival after radiation exposure. Germ-free conditions, probiotics and antibiotics are each identified as modifiers of disease development and course. A human study suggested that luminal microbiota composition may influence the host's intestinal response to radiation and may change in those developing postradiation diarrhea. SUMMARY: New knowledge implies that investigations aimed at deciphering the microbiome-host interactions before and after small bowl radiation injury may eventually allow prediction of disease course and offer opportunities for the development of novel therapeutic or prophylactic strategies.
PURPOSE OF REVIEW: Injury to the small bowel from ionizing radiation occurs commonly in patients undergoing cancer therapy and less commonly in instances of accidental radiation overexposure. Several lines of evidence now suggest that dynamic interactions between the host's enteric microbiota and innate immune system are important in modulating the intestinal response to radiation. Here, we will review recent developments in the area of acute radiation enteropathy and examine the current state of knowledge regarding the impact of host-microbial interactions in the process. RECENT FINDINGS: There is promise in the development and testing of new clinical biomarkers including serum citrulline. Toll-like receptor agonists and innate immune system signaling pathways including nuclear factor-kappa B profoundly alter intestinal epithelial cell apoptosis and crypt survival after radiation exposure. Germ-free conditions, probiotics and antibiotics are each identified as modifiers of disease development and course. A human study suggested that luminal microbiota composition may influence the host's intestinal response to radiation and may change in those developing postradiation diarrhea. SUMMARY: New knowledge implies that investigations aimed at deciphering the microbiome-host interactions before and after small bowl radiation injury may eventually allow prediction of disease course and offer opportunities for the development of novel therapeutic or prophylactic strategies.
Authors: Mahmoud R Hussein; Eman E Abu-Dief; Esam Kamel; Amal T Abou El-Ghait; Saad Rezk Abdulwahed; Mohamed H Ahmad Journal: Cell Biol Int Date: 2008-08-13 Impact factor: 3.612
Authors: Kang Kyoo Lee; Hyang Jeong Jo; Joon Pio Hong; Sang-Wook Lee; Jung Sook Sohn; Soo Young Moon; Sei Hoon Yang; Hyeok Shim; Sang Ho Lee; Seung-Hee Ryu; Sun Rock Moon Journal: Int J Radiat Oncol Biol Phys Date: 2008-07-15 Impact factor: 7.038
Authors: Wei Qiu; Eleanor B Carson-Walter; Hongtao Liu; Michael Epperly; Joel S Greenberger; Gerard P Zambetti; Lin Zhang; Jian Yu Journal: Cell Stem Cell Date: 2008-06-05 Impact factor: 24.633
Authors: M P Garin-Laflam; K A Steinbrecher; J A Rudolph; J Mao; M B Cohen Journal: Am J Physiol Gastrointest Liver Physiol Date: 2009-02-12 Impact factor: 4.052
Authors: Jordi Giralt; José Perez Regadera; Ramona Verges; Jesus Romero; Isabel de la Fuente; Albert Biete; Jesús Villoria; Jose Maria Cobo; Francisco Guarner Journal: Int J Radiat Oncol Biol Phys Date: 2008-02-19 Impact factor: 7.038
Authors: Matthew A Ciorba; Christopher L Hallemeier; William F Stenson; Parag J Parikh Journal: Curr Opin Support Palliat Care Date: 2015-06 Impact factor: 2.302
Authors: Velda J Gonzalez; Jason Beckstead; Maureen Groer; Susan McMillan; Desiree Ortiz; Sara Marrero; Leorey N Saligan Journal: P R Health Sci J Date: 2019-06 Impact factor: 0.705
Authors: Christopher D Packey; Michael T Shanahan; Sayeed Manick; Maureen A Bower; Melissa Ellermann; Susan L Tonkonogy; Ian M Carroll; R Balfour Sartor Journal: Gut Microbes Date: 2013-07-24
Authors: Fang Fang Zhang; Rohit P Ojha; Kevin R Krull; Todd M Gibson; Lu Lu; Jennifer Lanctot; Wassim Chemaitilly; Leslie L Robison; Melissa M Hudson Journal: J Nutr Date: 2016-10-19 Impact factor: 4.798
Authors: Eva C Guinan; Christine M Barbon; Leslie A Kalish; Kalindi Parmar; Jeff Kutok; Christy J Mancuso; Liat Stoler-Barak; Eugénie E Suter; Janice D Russell; Christine D Palmer; Leighanne C Gallington; Annie Voskertchian; Jo-Anne Vergilio; Geoffrey Cole; Kaya Zhu; Alan D'Andrea; Robert Soiffer; Jerrold P Weiss; Ofer Levy Journal: Sci Transl Med Date: 2011-11-23 Impact factor: 17.956
Authors: Kenneth J Janec; Huaiping Yuan; James E Norton; Rowan H Kelner; Christian K Hirt; Rebecca A Betensky; Eva C Guinan Journal: Am J Hematol Date: 2018-05-11 Impact factor: 10.047
Authors: Lulu Sun; Hiroyuki Miyoshi; Sofia Origanti; Timothy J Nice; Alexandra C Barger; Nicholas A Manieri; Leslie A Fogel; Anthony R French; David Piwnica-Worms; Helen Piwnica-Worms; Herbert W Virgin; Deborah J Lenschow; Thaddeus S Stappenbeck Journal: Cell Host Microbe Date: 2014-12-04 Impact factor: 21.023